<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Polymers (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Polymers (Basel)</journal-id><journal-id journal-id-type="pmc-domain-id">3589</journal-id><journal-id journal-id-type="pmc-domain">polymers</journal-id><journal-id journal-id-type="publisher-id">polymers</journal-id><journal-title-group><journal-title>Polymers</journal-title></journal-title-group><issn pub-type="epub">2073-4360</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12473257</article-id><article-id pub-id-type="pmcid-ver">PMC12473257.1</article-id><article-id pub-id-type="pmcaid">12473257</article-id><article-id pub-id-type="pmcaiid">12473257</article-id><article-id pub-id-type="pmid">41012262</article-id><article-id pub-id-type="doi">10.3390/polym17182497</article-id><article-id pub-id-type="publisher-id">polymers-17-02497</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>pH-Sensitive Naproxen Delivery via ZIF and Kaolin@ZIF Nanocarriers in 3D-Printed PLA&#8211;Gelatin Hydrogels</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>&#199;etin</surname><given-names initials="R">Reyhan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-polymers-17-02497" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0004-9007-8334</contrib-id><name name-style="western"><surname>Ates</surname><given-names initials="B">Berna</given-names></name><xref rid="af2-polymers-17-02497" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5960-2397</contrib-id><name name-style="western"><surname>Gok</surname><given-names initials="O">Ozgul</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af2-polymers-17-02497" ref-type="aff">2</xref><xref rid="af3-polymers-17-02497" ref-type="aff">3</xref><xref rid="c1-polymers-17-02497" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7386-5003</contrib-id><name name-style="western"><surname>Benli</surname><given-names initials="B">Birg&#252;l</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-polymers-17-02497" ref-type="aff">1</xref><xref rid="af4-polymers-17-02497" ref-type="aff">4</xref><xref rid="c1-polymers-17-02497" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Bikiaris</surname><given-names initials="D">Dimitrios</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-polymers-17-02497"><label>1</label>Nanoscience and Nanoengineering Graduate Program, &#304;stanbul Technical University, 34469 Istanbul, Turkey; <email>cetinr21@itu.edu.tr</email></aff><aff id="af2-polymers-17-02497"><label>2</label>Department of Biomedical Engineering, Graduate School of Natural and Applied Sciences, Ac&#305;badem Mehmet Ali Ayd&#305;nlar University, 34752 Istanbul, Turkey; <email>berna.ates@live.acibadem.edu.tr</email></aff><aff id="af3-polymers-17-02497"><label>3</label>Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Ac&#305;badem Mehmet Ali Ayd&#305;nlar University, 34752 Istanbul, Turkey</aff><aff id="af4-polymers-17-02497"><label>4</label>Department of Mineral Processing Engineering, &#304;stanbul Technical University, 34469 Istanbul, Turkey</aff><author-notes><corresp id="c1-polymers-17-02497"><label>*</label>Correspondence: <email>ozgul.gok@acibadem.edu.tr</email> (O.G.); <email>benli@itu.edu.tr</email> (B.B.); Tel.: +90-216-500-4188 (O.G.); +90-212-285-6267 (B.B.)</corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>18</issue><issue-id pub-id-type="pmc-issue-id">497668</issue-id><elocation-id>2497</elocation-id><history><date date-type="received"><day>01</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>21</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>31</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>16</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>27</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 18:25:14.327"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="polymers-17-02497.pdf"/><abstract><p>This study presents a pH-responsive drug delivery platform, created based on naproxen-loaded zeolitic imidazolate frameworks (ZIF) and kaolin-ZIF (Kao@ZIF) nanocarriers embedded in a 3D-printed polylactic acid (PLA) scaffold coated with a gelatin hydrogel. The PLA discs were designed as structural tissue models to simulate localized drug release. Kaolin (Kao), a basic mineral in the kaolin group that includes halloysite, was selected as a chemically stable and biocompatible adsorbent to enhance ZIF integrity and system reliability. To address the concerns about the safety and reproducibility of nanoscale materials in biomedical applications, structurally stable ZIF and Kao@ZIF nanocarriers were synthesized and characterized using FT-IR, SEM-EDS, and LC-M/MS, measuring drug loading efficiencies over 90% for ZIF and slightly higher for Kao@ZIF. In vitro release profiles showed strong pH sensitivity, with greater naproxen release at acidic pH (5.4) and more sustained release from Kao@ZIF. Cytotoxicity assays using L929 fibroblasts demonstrated improved biocompatibility, with cell viabilities of approximately 75% for ZIF&#8211;naproxen, 82% for Kao@ZIF&#8211;naproxen, and 90% for gelatin-coated PLA&#8211;Kao@ZIF scaffolds, for 24 h incubation. Incorporating kaolin-stabilized ZIF nanocarriers into 3D-printed biodegradable scaffolds offers a promising and safer approach for pH-sensitive, tissue-targeted drug delivery, while laying the groundwork for future studies involving halloysite-derived nanotubular systems.</p></abstract><kwd-group><kwd>pH-responsive drug delivery</kwd><kwd>zeolitic imidazolate framework (ZIF)</kwd><kwd>kaolin</kwd><kwd>nanocarrier</kwd><kwd>3D printing</kwd><kwd>polylactic acid (PLA)</kwd><kwd>gelatin hydrogel</kwd><kwd>naproxen</kwd></kwd-group><funding-group><award-group><funding-source>Istanbul Technical University</funding-source><award-id>MYL-2022-4379</award-id><award-id>MDA-2022-43800</award-id></award-group><award-group><funding-source>Ac&#305;badem Mehmet Ali Ayd&#305;nlar University</funding-source></award-group><funding-statement>This research was funded by Istanbul Technical University, grant number MYL-2022-4379 &amp; MDA-2022-43800. The APC was funded by Ac&#305;badem Mehmet Ali Ayd&#305;nlar University.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-polymers-17-02497"><title>1. Introduction</title><p>Advancements in nanotechnology have significantly transformed the field of drug delivery by enabling precise, targeted, and controlled therapeutic applications. Among these innovations, nanocarriers&#8212;nanoscale systems designed to encapsulate and transport drugs&#8212;have emerged as a key technology which improve solubility, bioavailability, and site-specific release [<xref rid="B1-polymers-17-02497" ref-type="bibr">1</xref>,<xref rid="B2-polymers-17-02497" ref-type="bibr">2</xref>]. These systems are broadly categorized into organic (e.g., liposomes, micelles, polymeric nanoparticles) and inorganic (e.g., metallic, ceramic, or hybrid materials) systems. While organic carriers offer biocompatibility and flexibility, they often suffer from structural instability and limited drug loading. Conversely, inorganic nanocarriers, particularly metal&#8211;organic frameworks (MOFs), provide structural integrity, large surface areas, and tunable porosity, making them ideal for stimuli-responsive drug delivery [<xref rid="B3-polymers-17-02497" ref-type="bibr">3</xref>,<xref rid="B4-polymers-17-02497" ref-type="bibr">4</xref>]. A particularly promising subclass of MOFs is the Zeolitic Imidazolate Frameworks (ZIFs), which combine the thermal and chemical stability of zeolites with the structural flexibility of organic linkers. ZIFs have gained attention for their high drug loading capacity, pH-responsive release profiles, and enhanced biocompatibility [<xref rid="B5-polymers-17-02497" ref-type="bibr">5</xref>,<xref rid="B6-polymers-17-02497" ref-type="bibr">6</xref>]. However, challenges such as limited colloidal stability, burst release, and clinical translation hinder their stand-alone use. To overcome these issues, hybrid systems that incorporate ZIFs with pharmaceutically crucial materials are being explored to overcome these issues.</p><p>In this study, kaolin (Kao@)&#8212;a naturally abundant, pharmacopeia-approved clay composed of hydrated aluminum silicate (Al<sub>4</sub>Si<sub>4</sub>O<sub>10</sub>(OH)<sub>8</sub>), with a theoretical chemical composition of 46.54% SiO<sub>2</sub>, 39.50% Al<sub>2</sub>O<sub>3</sub>, and 13.96% H<sub>2</sub>O&#8212;was selected as a support material to enhance the structural integrity, regulatory compliance, and biocompatibility of ZIF-based nanocarriers [<xref rid="B7-polymers-17-02497" ref-type="bibr">7</xref>]. Unlike halloysite nanotubes (HNTs), kaolin presents a non-tubular layered morphology, contributing to improved mechanical strength, thermal stability, and drug retention, while still allowing surface functionalization [<xref rid="B8-polymers-17-02497" ref-type="bibr">8</xref>]. Although kaolin has long been used as a pharmaceutical excipient (e.g., flow regulator or filler) and is recognized by both USP and Ph. Eur. Regulations [<xref rid="B9-polymers-17-02497" ref-type="bibr">9</xref>], its application as advanced nanocarrier systems (in cosmetics and wound healing materials, and integration with ZIFs in drug delivery platforms) remains largely unexplored. Traditionally considered an inert additive, kaolin&#8217;s high surface area, chemical stability, and favorable surface interactions make it an ideal substrate for anchoring ZIF crystals. Binding ZIFs onto kaolin surfaces (forming Kao@ZIF hybrids) offers several benefits, including enhanced colloidal stability, mitigated burst release, and preservation of ZIF&#8217;s functional properties&#8212;while maintaining compliance with pharmaceutical safety regulations.</p><p>To investigate this hybrid system, we synthesized and characterized both ZIF and Kao@ZIF nanocarriers, which were subsequently loaded with Naproxen, a model nonsteroidal anti-inflammatory drug (NSAID), to obtain a hybrid system. These nanocarriers were then embedded into a gelatin hydrogel and poly (lactic acid) (PLA) scaffold composite, forming a pH-responsive bio-composite patch with potential applications in topical and wound-targeted drug delivery. While ZIFs contribute high drug loading efficiency and better pH-responsive release behavior, the kaolin enhances mechanical stability and biocompatibility, offering a synergistic approach to controlled therapeutic delivery approach.</p><p>By merging the performance advantages of ZIFs with the regulatory reliability and safety profile of kaolin, this study introduces a clinically relevant hybrid nanocarrier design that bridges the gap between innovative materials and translational medicine. Accordingly, we investigated the physicochemical and biological performance of the Kao@ZIF system, focusing on drug loading, release kinetics, and cytocompatibility.</p><p>Simultaneously, PLA was selected as a scaffold material for its mechanical durability and biodegradability as a scaffold material, and gelatin hydrogel for its excellent biocompatibility and capacity to mimic the natural extracellular matrix. This PLA&#8211;gelatin-matrix, reinforced with either ZIF or Kao@ZIF nanocarriers, was fabricated via 3D printing to generate drug-loaded patches tailored for localized, sustained release applications.</p><p>Naproxen was chosen for its clinical relevance and pH-sensitive solubility, which makes it an ideal candidate for evaluating stimuli-responsive delivery platforms. As a weakly acidic molecule, its solubility varies significantly across physiologically relevant pH levels, making it well-suited for mimicking drug behavior in environments such as the gastrointestinal tract or wound sites.</p><p>Overall, this study presents a novel approach that leverages the complementary properties of ZIFs and kaolin, embedded within a hydrogel&#8211;PLA matrix, to create an effective, biocompatible, and regulation-facilitating drug delivery platform suitable for NSAID administration and potentially adaptable to broader therapeutic applications.</p></sec><sec id="sec2-polymers-17-02497"><title>2. Materials and Methods</title><sec id="sec2dot1-polymers-17-02497"><title>2.1. Materials</title><p>Polylactic Acid (PLA) filament (1.75 mm, matte black, eSUN, Shenzhen, China), pure gelatin powder (food quality) and glutaraldehyde solution (25% <italic toggle="yes">w</italic>/<italic toggle="yes">w</italic> in water; GA, Santa Cruz Biotechnology, Dallas, TX, USA), ethanol (EtOH, &#8805;70%, Sigma-Aldrich, St. Louis, MO, USA), Kaolin (Kao, powder, Santa Cruz Biotechnology, Dallas, TX, USA), zinc acetate dihydrate (Sigma-Aldrich, St. Louis, MO, USA), 2-methylimidazole (2-mIM, &gt;99%, Isolab, Eschau, Germany) was used. Naproxen, as the model drug, was obtained from Santa Cruz Biotechnology. For nanocarrier characterization and drug loading/release analysis, phosphate-buffered saline (PBS, pH 7.4, Bioshop, Burlington, ON, Canada) and acetate buffer solution (pH 5.2, Sigma-Aldrich, St. Louis, MO, USA) were employed. Cell Counting Kit-8 (CCK-8) was used to assess cell viability and toxicity against L929 fibroblast cells.</p></sec><sec id="sec2dot2-polymers-17-02497"><title>2.2. Design and Fabrication of the PLA Scaffold</title><p>A circular model with one central hole and seven surrounding pore holes was designed for fabricating the PLA scaffold using Autodesk Fusion 360, Autodesk Inc., San Rafael, CA, USA. The diameter of the disc was 30 mm, with the surrounding pores being 5 mm in diameter and the central hole 7 mm, as shown in <xref rid="polymers-17-02497-f001" ref-type="fig">Figure 1</xref>a. The height of the scaffold was set to 2 mm (<xref rid="polymers-17-02497-f001" ref-type="fig">Figure 1</xref>b). Scaffolds of this low height provide temporary structural support while being easily removable and minimizing material consumption. In biomedical applications, this design enhances cell attachment and tissue integration, improves biocompatibility while interacting with the host environment, and facilitates controlled drug release by promoting the efficient diffusion of bioactive agents. Additionally, it offers practical advantages including improved print quality, ease of handling, aesthetic appeal, and post-processing convenience, making it a preferred configuration.</p><p>The PLA scaffold designed in this study was inspired by 3D-printed PLA-based scaffolds coated with hydrogel layers as reported by Schneider et al. [<xref rid="B10-polymers-17-02497" ref-type="bibr">10</xref>], aiming to support the biological performance of the final construct in nanomedicine and drug delivery applications. The model shown in <xref rid="polymers-17-02497-f001" ref-type="fig">Figure 1</xref>a was exported as an STL file using Autodesk Fusion 360. The STL file was arranged horizontally in Ultimaker Cura 5.0.0 (Ultimaker B.V., Utrecht, The Netherlands) to maximize yield on the build plate. G-code was generated with the following settings: 20% infill density, build plate adhesion enabled, and no support structure. Additional 3D printer settings were configured as follows: nozzle temperature 200 &#176;C, bed temperature 60 &#176;C, and print speed 50 mm/s. PLA scaffolds were printed horizontally using a Creality Ender-3 V2 (Shenzhen Creality 3D Technology Co., Shenzhen, China) fused deposition modeling (FDM) printer.</p></sec><sec id="sec2dot3-polymers-17-02497"><title>2.3. Preparation of PLA Scaffolds Embedded with Gelatin and Modified with Glutaraldehyde</title><p>The dry weights of the PLA scaffolds (W<sub>PLA</sub>) were recorded before the coating process. The scaffolds were then placed in Petri dishes, and a 10% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) gelatin solution was applied to all surfaces. Approximately 25 mL of gelatin solution was coated onto each scaffold (<xref rid="polymers-17-02497-f001" ref-type="fig">Figure 1</xref>c). The scaffolds were left to dry overnight in a hood, resulting in a total of 12 layers of gelatin-coated PLA scaffolds. After drying, the scaffolds were weighed again to determine the gelatin uptake (W<sub>PLA&amp;Gelatin</sub>).</p><p>Glutaraldehyde was employed as a crosslinking agent due to its widespread use in tissue and bioengineering to enhance the mechanical stability of water-soluble biopolymers like gelatin. It reduces gelatin solubility, increases water resistance, improves durability, and may confer antimicrobial properties. In this process, a 50% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) glutaraldehyde solution was prepared in 60 mL of distilled water and distributed in 5 mL portions into Petri dishes containing the dried gelatin-coated scaffolds. The Petri dishes were placed in a hood overnight to allow crosslinking of the gelatin polymer chains. Following this, the scaffolds were rinsed with distilled water to remove excess reagent. The samples were then frozen at &#8722;80 &#176;C overnight and subsequently lyophilized at the same temperature (<xref rid="polymers-17-02497-f001" ref-type="fig">Figure 1</xref>d). Final weights were recorded to calculate the hydrogel mass formed on scaffolds. The weight of gelatin hydrogel (W<sub>gel</sub>) was determined following the method described by Motakef-Kazemi et al. [<xref rid="B11-polymers-17-02497" ref-type="bibr">11</xref>], using Equation (1), where the dry weight of the PLA scaffold (WPLA) was considered negligible and thus excluded from further calculations:<disp-formula id="FD1-polymers-17-02497"><label>(1)</label><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">W</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">W</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mo>&amp;</mml:mo><mml:mi mathvariant="normal">G</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">W</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec2dot4-polymers-17-02497"><title>2.4. Synthesis of ZIF Nanocarriers</title><p>Typically, water-based synthesis methods have been used to prepare ZIF nanocrystals at room temperature [<xref rid="B12-polymers-17-02497" ref-type="bibr">12</xref>,<xref rid="B13-polymers-17-02497" ref-type="bibr">13</xref>], and were followed in this study as described: 1968 mg of 2-methylimidazole (2-mIM) and 2634 mg of zinc acetate were separately dissolved in 150 mL of distilled water, with stirring at 400 rpm for 2 h at room temperature (~23 &#177; 2 &#176;C). The zinc acetate solution was then added to the 2-mIM solution. After aging for 2 h, the resulting precipitate was transferred to 50 mL falcon tubes and separated via centrifugation at 4000 rpm for 20 min. The obtained ZIF precipitates were washed three times with distilled water and then transferred to the Petri dishes. To facilitate drying, the Petri dishes were covered with perforated Parafilm and left overnight in a fume hood. The dried samples were then used for further characterization.</p></sec><sec id="sec2dot5-polymers-17-02497"><title>2.5. Synthesis of Kao@ZIF Nanocarrier Composites</title><p>Kaolin (0.35 g) was dispersed in 10 mL of EtOH, and 1653 mg of 2-mIM was dissolved in 40 mL of EtOH and stirred with ultrasound for 30 min in the hood. This solution was then mixed with 0.439 g of zinc acetate dihydrate dissolved in 10 mL of EtOH, following a modified method based on Hou and Wu [<xref rid="B14-polymers-17-02497" ref-type="bibr">14</xref>]. After an additional 30 min of sonification to ensure complete dispersion, the composite solution was transferred to 50 mL falcon tubes and centrifuged at 4000 rpm for 20 min. The resulting white precipitate, corresponding to Kao@ZIF nanocomposites, was washed three times with EtOH and several times with distilled water. The final product was placed in a Petri dish, covered with perforated parafilm, and dried overnight in a hood. The dried Kao@ZIF nanocarriers were used for subsequent analysis, and SEM images were obtained for both ZIF and Kao@ZIF samples.</p></sec><sec id="sec2dot6-polymers-17-02497"><title>2.6. Fabrication of Naproxen-Loaded ZIF and Kao@ZIF Composite for PLA-Embedded Glutaraldehyde-Modified Gelatin Hydrogel</title><p>The fabrication of Naproxen-loaded ZIF and Kao@ZIF composites began with the preparation of a 10% (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>) Naproxen stock solution, in which 1 mg of Naproxen was dissolved in 200 &#181;L of absolute EtOH using a vortex mixer. For drug loading, 10 mg of synthesized ZIF was dispersed in 5 mL of EtOH and stirred magnetically for 1 h. Then, 1 mL of the prepared Naproxen solution was added to the ZIF dispersion, and the mixture was stirred at 200 rpm for 2 h.</p><p>The resulting suspension was transferred into 50 mL falcon tubes and centrifuged at 4000 rpm for 20 min. After phase separation, the supernatant was collected using a micropipette to determine the concentration of unbound Naproxen. The precipitate, referred to as Nap-ZIF, was washed with distilled water and dried under ambient conditions in a petri dish.</p><p>A similar procedure was followed for the Kao@ZIF composite: 10 mg of Kao@ZIF was suspended in 5 mL of absolute EtOH and stirred magnetically for 1 h. Then, 1 mg of the Naproxen solution was added, followed by stirring at 200 rpm for 2 h. After mixing, the solution was centrifuged under the same conditions. The supernatant was collected for the analysis of drug loading efficiency, and the precipitate, referred to as Nap-Kao@ZIF, was washed with distilled water and dried in a Petri dish. To accelerate drying, the dish was covered with perforated Parafilm and placed in a fume hood overnight. This loading procedure was repeated in subsequent cycles as needed. <xref rid="polymers-17-02497-f002" ref-type="fig">Figure 2</xref> presents a schematic illustration of the nanocarrier synthesis procedure, showing the formation of ZIF-8 and Kao@ZIF from zinc nitrate dihydrate and 2-mIM as the primary precursors.</p></sec><sec id="sec2dot7-polymers-17-02497"><title>2.7. Drug Loading of Nanocarriers</title><p>First, 1 mg of Naproxen was dissolved in 200 &#956;L of EtOH using a vortex mixer to prepare a 10% (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>) drug solution. Then, 10 mg of ZIF or Kao@ZIF was dispersed in 5 mL of EtOH and stirred magnetically for 1 h. Following this, 200 &#956;L of the Naproxen solution (containing 1 mg of drug) was added to the ZIF dispersion and stirred at 200 rpm for 2 h [<xref rid="B11-polymers-17-02497" ref-type="bibr">11</xref>]. The mixture was transferred into 50 mL falcon tubes and centrifuged at 4000 rpm for 20 min. A sample of the supernatant was collected using a micropipette to measure the drug concentration. The resulting precipitate, referred to as Nap-ZIF, was washed with distilled water and placed in a Petri dish. The Petri dish was covered with perforated parafilm and left to dry overnight in the hood. The drug loading efficiency (DLE) was calculated using the concentration values obtained from the supernatant, according to Equation (3).<disp-formula id="FD2-polymers-17-02497"><label>(2)</label><mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Drug Loading Efficiency</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">%</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">Amount of drug loaded</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Initial amount of drug</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#215;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
The drug release profile and pH responsiveness of the Naproxen-loaded ZIF and Kao@ZIF composites embedded in the PLA-gelatin hydrogel were evaluated based on the protocols described by Sun et al. [<xref rid="B5-polymers-17-02497" ref-type="bibr">5</xref>] and Cao et al. [<xref rid="B15-polymers-17-02497" ref-type="bibr">15</xref>]. For drug release analysis, each gelatin hydrogel sample was immersed in 100 mL PBS (pH 7.4) in an orbital shaker at low speed. Aliquots were collected daily over a 15-day period, stored in vials, and analyzed using LC-M/MS to determine the cumulative drug release. For pH responsiveness, each hydrogel was placed in 100 mL of acetate buffer (pH 5.4) with identical shaking conditions. Daily samples were again collected for 15 days, stored, and analyzed similarly to measure Naproxen release under acidic conditions.</p></sec><sec id="sec2dot8-polymers-17-02497"><title>2.8. Characterization</title><p>The chemical composition of the prepared nanocarriers and hydrogel scaffolds was analyzed by attenuated total reflectance (ATR) Fourier-transform infrared spectroscopy (FT-IR) spectroscopy (ThermoScientific NICOLET iS10) (Waltham, MA, USA) with 64 scans in the range of at 3500&#8211;500 cm<sup>&#8722;1</sup>.</p><p>Scanning electron microscopy (SEM) analysis was performed using a Thermo Fisher Scientific Quanta650) (Waltham, MA, USA), after coating with a 50 nm thick gold layer and using ETD under vacuum. SEM images were captured at 20 kV with a 3.5 spot size. Energy-dispersive X-ray spectroscopy (EDS) was conducted using an Oxford Instruments INCAx-act detector (Oxford Instruments, Uedem, Germany) at an acceleration voltage of 15 kV. Prior to SEM and EDS analysis, all samples including Kao@ZIF, ZIF, PLA-hydrogel, Kao@ZIF loaded PLA-hydrogel and ZIF loaded PLA-hydrogel were carbon-coated using a POLARON CC7650 carbon coater (Quorum Technologies Ltd., Laughton, East Sussex, UK). Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS; Agilent Technologies 6420 TripleQuad, Agilent Technologies Inc., Santa Clara, CA, USA) was used to measure both the amount of Naproxen loaded into the nanocarriers and the amount released during in vitro experiments.</p><p>To assess the swelling behavior and degradation rate of the fabricated PLA-gelatin hydrogels, samples were immersed separately in distilled water and PBS solution. Since the PLA scaffold was encapsulated within gelatin, the PLA weight was excluded from all calculations. Initial weights (Wo) were recorded after gently blotting excess surface moisture with a laboratory tissue. Samples were then immersed in 100 mL of solution and incubated at 37 &#176;C. Changes in sample weight over time (W<sub>t</sub>) were monitored up to 120 min, until equilibrium was reached.</p><p>Depending on whether the sample swelled or degraded, the final weight either increased or decreased [<xref rid="B16-polymers-17-02497" ref-type="bibr">16</xref>,<xref rid="B17-polymers-17-02497" ref-type="bibr">17</xref>]. The swelling or degradation ratio at a specific time was calculated using Equation (3).<disp-formula id="FD3-polymers-17-02497"><label>(3)</label><mml:math id="mm3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Swelling or Degradation ratio</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">%</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">W</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi mathvariant="normal">W</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">W</mml:mi><mml:mi mathvariant="normal">o</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#215;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>The drug release mechanism was analyzed using the Ritger&#8211;Peppas model (Equation (4)) from the cumulative naproxen release data. The release fraction (M<sub>t</sub>/M<sub>&#8734;</sub>) was normalized to unity, and log&#8211;log plots of the release fraction versus time were used to determine the release exponent (<italic toggle="yes">n</italic>) and kinetic constant (k) through linear regression. This model was employed to provide further insight into the release mechanism of ZIF and Kao@ZIF nanocarriers under different pH conditions.<disp-formula id="FD4-polymers-17-02497"><label>(4)</label><mml:math id="mm4" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo>&#8734;</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mtext>&#160;</mml:mtext><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec2dot9-polymers-17-02497"><title>2.9. In Vitro Cyctotoxicity Assay</title><p>These experiments were conducted to evaluate the cytotoxicity of various nanocarrier formulations and their corresponding hydrogels, which are essential parameters for assessing their potential in therapeutic applications. L929 mouse fibroblast cells were cultured in Dulbecco&#8217;s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin&#8211;streptomycin&#8211;amphotericin B (PSA) as described by Karaca et al. [<xref rid="B18-polymers-17-02497" ref-type="bibr">18</xref>]. The cells stored at &#8722;80 &#176;C were thawed according to the manufacturer&#8217;s instructions and seeded into culture dishes. The cells were incubated at 37 &#176;C in a 5% CO<sub>2</sub> atmosphere, and the culture medium was refreshed every 48 h. When the cells reached approximately 80% confluency, they were detached using trypsin, centrifuged, and resuspended in fresh medium. The number of viable cells was determined using a hemotocytometer, and the cytotoxicity tests were conducted as triplicates (<italic toggle="yes">n</italic> = 3) in 96-well plates. The following samples were prepared as follows: free drug, ZIF, Kao@ZIF, ZIF&#8211;Naproxen, Kao@ZIF&#8211;Naproxen, Hydrogel&#8211;ZIF, Hydrogel&#8211;Kao@ZIF, Hydrogel&#8211;ZIF&#8211;Naproxen, and Hydrogel&#8211;Kao@ZIF&#8211;Naproxen. For the nanocarrier groups, 20 mg of each formulation was suspended in 1000 &#181;L of DMEM. For the release of the drug molecules, the prepared solutions were incubated in an orbital shaker. Afterwards, 2 mL of each solution was collected into falcon tubes. From each, 200 &#181;L was transferred into eppendorf tubes and diluted 1:4 with fresh DMEM. As controls, positive (cells + medium) and negative (medium only) groups were included in the 96-well plates. For the assay, 200 &#956;L of each test sample was added to the first well of each row, followed by three consecutive 1:2 serial dilutions into the adjacent wells.</p></sec></sec><sec sec-type="results" id="sec3-polymers-17-02497"><title>3. Results</title><sec id="sec3dot1-polymers-17-02497"><title>3.1. Structural Characterization of ZIF and Kao@ZIF Nanocarriers via FT-IR Analysis</title><p>Zeolitic Imidazolate Frameworks (ZIFs), synthesized from zinc acetate dihydrate and 2-methylimidazole (2-mIM), along with natural clay materials such as kaolin, are promising candidates for use in biomedical nanocarrier systems, particularly for applications like wound dressings and localized drug delivery. When integrated with poly(lactic acid) (PLA), these materials contribute to scaffold architectures that enhance structural integrity, promote cell proliferation, and support tissue regeneration. The biodegradability and mechanical properties of PLA further complement long-term in vivo applications.</p><p>The successful synthesis of ZIFs was confirmed by FT-IR spectroscopy, which revealed characteristic peaks corresponding to -N-H stretching, C=C and C=N stretching, as well as -N-H bending vibrations (<xref rid="polymers-17-02497-f003" ref-type="fig">Figure 3</xref>). Similarly, the FT-IR spectrum of pure Naproxen exhibited characteristic bands such as -Ar-H bending, C-O bending, C=O stretching, and COOH vibrations (-Ar refers to aromatic groups), serving as critical references for identifying Naproxen in the drug-loaded nanocarrier systems (<xref rid="app1-polymers-17-02497" ref-type="app">Supplementary Figure S1</xref>).</p><p>The Kao@ZIF composite spectrum (<xref rid="polymers-17-02497-f004" ref-type="fig">Figure 4</xref>), demonstrated peaks from both ZIF and kaolin components:<list list-type="simple"><list-item><label>-</label><p>ZIFspecific bands: NH and OH stretching, C=C and C=N stretching</p></list-item><list-item><label>-</label><p>Kaolinspecific bands: SiO bending and AlOH bending</p></list-item></list></p><p>These distinct spectral features confirm the successful integration of ZIF structure onto the kaolin surface, validating the formation of the Kao@ZIF composite.</p><list list-type="simple"><list-item><label>-</label><p>In the FTIR spectrum of Kao@ZIFNaproxen, several characteristic bands corresponding to Naproxen (e.g., C=O stretching at ~1720 cm<sup>&#8722;1</sup> and COOH vibration bands) were observed, which were absent in the pristine Kao@ZIF spectrum. This confirms the successful incorporation of Naproxen within the Kao@ZIF matrix. Additionally, slight shifts in ZIFrelated peaks (such as C=N and NH stretching vibrations) suggest possible interactions between the drug and the ZIF, likely through hydrogen bonding or coordination with zinc ions. These spectral changes further support the formation of a stable drug&#8211;carrier composite structure (<xref rid="polymers-17-02497-f004" ref-type="fig">Figure 4</xref>).</p></list-item></list></sec><sec id="sec3dot2-polymers-17-02497"><title>3.2. Morphological and Elemental Characterization (SEM-EDS)</title><p>To investigate the morphological and surface characteristics of the synthesized nanocarriers and their composite formulations, scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS) analyses were conducted. The synthesized ZIF particles exhibited a sheet-like morphology (<xref rid="polymers-17-02497-f005" ref-type="fig">Figure 5</xref>a), with sizes ranging from 451.8 nm to 1.53 &#956;m. This observation is consistent with previous findings [<xref rid="B13-polymers-17-02497" ref-type="bibr">13</xref>] and is further supported by the particle size distribution shown in <xref rid="app1-polymers-17-02497" ref-type="app">Supplementary Figure S2</xref>. Kao@ZIF nanocarriers, shown in <xref rid="polymers-17-02497-f005" ref-type="fig">Figure 5</xref>b, presented a relatively uniform and cubic-like morphology with particle sizes ranging from 48.6 nm to 55.5 nm. The SEM images confirmed the successful deposition of ZIF crystal on the kaolin surface, indicating the effective formation of a hybrid nanostructure. Compared to other clay-based supports like halloysite nanotubes reported in previous studies [<xref rid="B14-polymers-17-02497" ref-type="bibr">14</xref>] the non-tubular layered structure of kaolin still enabled efficient crystal deposition, albeit with potential differences in surface area and morphology. Additionally, the morphology of a synthesized Kao@ZIF composite, prepared as a control nanocarrier system, is presented in <xref rid="app1-polymers-17-02497" ref-type="app">Supplementary Figure S3</xref>. The SEM image reveals uniform ZIF deposition on the Kao@surface, demonstrating a successful hybrid coating approach.</p><p>The microstructure of the gelatin hydrogel revealed densely packed polymer layers and limited pore size, suggesting a high crosslinking density that enhances mechanical stability. The PLA&#8211;gelatin interface is illustrated in <xref rid="polymers-17-02497-f005" ref-type="fig">Figure 5</xref>c, with PLA appearing as the denser region on the left. <xref rid="polymers-17-02497-f006" ref-type="fig">Figure 6</xref>a,b show Naproxen-loaded ZIF and Kao@ZIF nanocarriers embedded in PLA&#8211;gelatin hydrogels, where nanocarrier aggregates are visible on the surface, indicating effective encapsulation and drug loading. Although the nanoparticles are partially embedded within the hydrogel matrix and may not appear as distinct entities at lower magnifications, the presence of characteristic granular surface features that are absent in the pure hydrogel strongly indicates successful incorporation of the nanocarriers into the scaffold.</p><sec><title>Elemental Composition Was Determined by EDS Analysis</title><p>Energy-dispersive X-ray spectroscopy (EDS) analysis was conducted to verify the elemental composition and confirm the successful synthesis and integration of the nanocarrier systems into the PLA&#8211;gelatin hydrogel matrix. In the case of the gelatin hydrogel alone (<xref rid="polymers-17-02497-f007" ref-type="fig">Figure 7</xref>a), peaks corresponding primarily to carbon (C), oxygen (O), and gold (Au) were observed. The presence of Au is attributed to the gold sputter coating applied during SEM sample preparation, while C and O reflect the organic composition of gelatin. The EDS spectrum of the Kao@ZIF nanocarriers (<xref rid="polymers-17-02497-f007" ref-type="fig">Figure 7</xref>b) showed distinct peaks for aluminum (Al), silicon (Si), and zinc (Zn), confirming the successful combination of kaolin and ZIF components within the hybrid structure. For the ZIF-only samples (<xref rid="polymers-17-02497-f007" ref-type="fig">Figure 7</xref>c), a strong Zn signal was detected, consistent with the presence of zinc-based metal&#8211;organic framework structures. When Kao@ZIF nanocarriers were embedded in the gelatin hydrogel matrix (<xref rid="polymers-17-02497-f007" ref-type="fig">Figure 7</xref>d), the continued presence of Al, Si, and Zn signals confirmed the structural stability and uniform distribution of the nanocarriers within the composite. The EDS spectrum further confirmed the elemental composition of Naproxen-loaded ZIF was obtained from the EDS spectrum presented in <xref rid="app1-polymers-17-02497" ref-type="app">Supplementary Figure S4</xref>, which revealed the continued presence of Zn peaks, indicating the structural integrity of the ZIF after drug loading. Overall, EDS data verified that the elemental fingerprints of both ZIF and kaolin were preserved in the composite systems, supporting the successful fabrication of the drug delivery platforms with consistent chemical integrity across all formulations.</p><p>EDS analysis further validates the successful fabrication of the Kao@ZIF composite by confirming the simultaneous presence of Zn (from ZIF) and Al/Si (from kaolin). This coexistence of characteristic elements provides direct evidence of the hybrid structure, complementing the morphological observations from SEM images.</p></sec></sec><sec id="sec3dot3-polymers-17-02497"><title>3.3. Drug Loading Efficiency of ZIF and Kao@ZIF Systems</title><p>Naproxen loading efficiencies exceeded 90% in both the ZIF and Kao@ZIF systems, highlighting their strong potential as nanocarriers for NSAIDs. Kao@ZIF consistently demonstrated slightly higher drug loading capacity compared to ZIF, likely due to its increased surface area and porous structure (<xref rid="polymers-17-02497-f008" ref-type="fig">Figure 8</xref>). This performance underscores the promise of Kao@ZIF as an effective platform for encapsulating poorly water-soluble drugs like Naproxen. In the first loading experiment, drug encapsulation efficiencies were calculated as 92.17% for ZIF&#8211;Naproxen and 92.95% for Kao@ZIF&#8211;Naproxen embedded into PLA&#8211;gelatin hydrogels. Similarly, free-form nanocarriers (not embedded in hydrogel) showed 91.48% efficiency for ZIF and 93.49% for Kao@ZIF. <xref rid="polymers-17-02497-t001" ref-type="table">Table 1</xref> summarizes drug loading efficiencies following the initial and secondary loading cycles.</p><p>In the second loading trial, ZIF-based hydrogels demonstrated a slight increase in efficiency (95.05%), whereas Kao@ZIF-based hydrogels showed a decreased value of 83.71%, potentially due to preparation inconsistencies or interfacial interference within the gel matrix (<xref rid="polymers-17-02497-t001" ref-type="table">Table 1</xref>). Despite this variability, non-embedded drug-loaded carriers still exhibited excellent performance&#8212;96.59% for ZIF and 99.14% for Kao@ZIF, confirming the strong affinity of Naproxen to both frameworks. Integrating ZIF structures onto kaolin surfaces (forming Kao@ZIF hybrids) offers multiple advantages: it moderates burst release, enhances dispersion stability, and preserves the functional characteristics of the nanocarrier, all while aligning with pharmacopeial safety standards. These attributes position Kao@ZIF as a clinically relevant and structurally robust hybrid nanocarrier.</p><p>In this study, ZIF and Kao@ZIF nanocarriers were further incorporated into a PLA&#8211;gelatin hydrogel matrix, forming a pH-responsive biocomposite patch suitable for topical or wound-related drugs. While ZIFs contribute high drug loading efficiency and pH-sensitive release behavior, kaolin enhances mechanical integrity and offers regulatory familiarity, enabling a synergistic platform for sustained and localized delivery. Nonetheless, the inherently low adsorption capacity of kaolin may pose a limitation in applications requiring high drug payloads. Although kaolin remains favorable due to its structural integrity, widespread pharmaceutical acceptance, and regulatory compliance, its relatively modest drug retention performance indicates that the current system is still open to further optimization. One potential contributing factor is the limited incorporation of the active compound during the embedding process, which may reduce drug&#8211;carrier interactions or internal loading efficiency.</p><p>Despite these constraints, a notable strength of the Kao@ZIF system lies in its ability to maintain structural integrity throughout synthesis, drug loading, and incorporation into the PLA&#8211;gelatin matrix. The preservation of composite morphology and the absence of degradation during processing highlight the system&#8217;s mechanical and chemical robustness, an encouraging result for sustained drug delivery applications.</p><p>Future research should explore the refinement of this hybrid approach by leveraging clay minerals such as halloysite nanotubes (HNTs), which offer higher specific surface areas and a tubular structure that could further improve adsorption behavior and controlled release properties. Thus, while the Kao@ZIF-based system demonstrates promising characteristics, it remains a platform that is open to enhancement and evolution for broader therapeutic applicability.</p></sec><sec id="sec3dot4-polymers-17-02497"><title>3.4. pH-Responsive Drug Release Behavior</title><p>To assess the drug release profiles of the loaded drug and the pH-responsiveness of the nanocarriers, in vitro drug release studies were conducted over a 15-day period. Naproxen-loaded ZIF and Kao@ZIF nanocarriers embedded within PLA&#8211;gelatin hydrogels were incubated separately in two different buffer environments: phosphate-buffered saline (PBS, pH 7.4) and acetate buffer (pH 5.5), mimicking physiological and slightly acidic conditions, respectively.</p><p>Quantitative analysis was performed using LC-M/MS based on a calibration curve constructed using free Naproxen. The calibration curve for free Naproxen was constructed based on standard solutions, yielding the linear equation y = 57.8244x + 2217.7404 with a high correlation coefficient of R<sup>2</sup> = 0.9808, indicating excellent linearity and reliability of the analytical method. A specific multiple reaction monitoring (MRM) analysis method was developed specific to Naproxen with an m/z value of 154.9 in the negative mode. The release profiles revealed that drug release from both nanocarrier systems was significantly higher under acidic conditions (pH 5.5) compared to neutral conditions (pH 7.4), with up to a 4.5-fold increase in cumulative release (<xref rid="polymers-17-02497-f008" ref-type="fig">Figure 8</xref>). These results confirm the pH-sensitive release behavior of both ZIF and Kao@ZIF systems, underscoring their potential for applications in acidic microenvironments such as inflamed or tumor tissues.</p><p>Between the two systems, Kao@ZIF exhibited slightly enhanced drug release rates under both pH conditions compared to ZIF alone. This effect can be attributed to the increased porosity and surface interaction provided by the kaolin matrix, which may facilitate more efficient drug diffusion. These findings suggest that integrating ZIF structures into kaolin substrates not only preserves the pH-responsive characteristics of the MOF but also contributes to a more sustained and controlled release pattern. In addition to the release data, it was observed that the PLA&#8211;gelatin hydrogel matrices preserved their physical integrity under both pH 5.4 and pH 7.4 conditions during the experimental period. No visible disintegration or collapse was detected, and the gels remained structurally stable while undergoing controlled swelling. This stability is consistent with the sustained and pH-sensitive release behaviors shown in <xref rid="polymers-17-02497-f008" ref-type="fig">Figure 8</xref>, confirming that the hydrogel matrices provide a reliable platform for drug delivery in different pH environments.</p></sec><sec id="sec3dot5-polymers-17-02497"><title>3.5. Kinetic Modeling</title><p>To further elucidate the release mechanism, the naproxen release profiles were fitted to the Ritger&#8211;Peppas model. The obtained kinetic parameters are summarized in <xref rid="polymers-17-02497-t002" ref-type="table">Table 2</xref>. At pH 5.5, ZIF exhibited an <italic toggle="yes">n</italic> value of 0.83, indicating anomalous transport governed by a combination of diffusion and swelling. In contrast, Kao@ZIF presented an <italic toggle="yes">n</italic> value close to unity, suggesting Case II transport behavior, consistent with its more sustained and matrix-controlled release. At pH 7.4, both carriers showed <italic toggle="yes">n</italic> values &#8805;1.0, characteristic of Case II or super Case II transport, reflecting slower and more relaxation-controlled release mechanisms under physiological conditions. These results align well with the experimental release profiles and further confirm the stabilizing effect of kaolin incorporation into the nanocarrier system.</p></sec><sec id="sec3dot6-polymers-17-02497"><title>3.6. Swelling and Degradation Behavior of PLA-Gelatin Hydrogels</title><p>To evaluate the fluid absorption capacity and potential release kinetics of the hydrogel matrix, the swelling behavior of the PLA&#8211;gelatin composite was assessed in vitro. The hydrogel exhibited rapid fluid uptake, reaching a peak swelling capacity of 2822.1 mg within the first 2 min (<xref rid="polymers-17-02497-f009" ref-type="fig">Figure 9</xref>). After this point, the swelling plateaued and remained stable for at least 2 h, with no remarkable mass loss or degradation. This rapid fluid absorption followed by structural equilibrium indicates that the PLA&#8211;gelatin matrix possesses excellent integrity and retention properties. Notably, this early swelling phase is critical for topical and localized drug delivery applications, where the hydrogel must quickly absorb exudates or surrounding fluids while maintaining mechanical stability and enabling a controlled release profile during the initial therapeutic window [<xref rid="B19-polymers-17-02497" ref-type="bibr">19</xref>].</p><p>The average dry weights of the PLA-only scaffolds, PLA&#8211;gelatin coated scaffolds, and PLA&#8211;gelatin hydrogels are summarized in <xref rid="app1-polymers-17-02497" ref-type="app">Supplementary Table S1</xref>, highlighting the increase in mass upon gelatin and hydrogel integration. The weight gain observed across samples reflects successful hydrogel incorporation and further supports the composite&#8217;s swelling capacity. It is important to note that the swelling behavior of the PLA&#8211;gelatin hydrogel does not directly affect the drug loading efficiency, since naproxen was loaded into the ZIF and Kao@ZIF nanocarriers prior to embedding. However, hydrogel swelling strongly influences the release stage: by absorbing fluid and expanding its network, the hydrogel increases porosity and creates diffusion channels that facilitate the controlled release of the drug from the nanocarriers. This highlights that swelling is a critical factor for regulating drug release rather than initial loading.</p></sec><sec id="sec3dot7-polymers-17-02497"><title>3.7. Cytotoxicity Assay</title><p>The CCK-8 cell viability assay was performed against L929 mouse fibroblast cell line for evaluating the cytotoxicity of prepared samples, together with their control groups. Drug concentrations ranging from 2 to 0.031 &#956;g/mL were tested on fibroblasts for 24 h incubation. Free Naproxen (NAP) was seen to give a dose-dependent cytotoxicity, especially for higher doses, which yielded 0.349 &#181;g/mL as EC<sub>50</sub> value. As carriers, ZIF and Kao@ZIF samples were in non-toxic regions, up to 5.5 and 1.4 &#956;g/mL. On the other hand, their drug-loaded versions (ZIF-NAP and Kao@ZIF-NAP) were found to improve the cell viability by shifting the threshold concentration of drug to more non-toxic region. As illustrated in <xref rid="polymers-17-02497-f010" ref-type="fig">Figure 10</xref>, the ZIF-NAP sample still remains in the safe cytotoxicity range up to 5.5 &#956;g/mL, while their Kao@-added versions seem to provide more cell viability up to 2.75 &#956;g/mL. These results suggest the ameliorating effect of this hydrogel system with drug-bearing Kao@ and ZIF complex, indicating the controlled release of free drug molecules to the environment.</p></sec></sec><sec sec-type="discussion" id="sec4-polymers-17-02497"><title>4. Discussion</title><p>Nanocarriers represent a significant development in drug delivery systems, providing improved therapeutic efficacy, elevated bioavailability, and the targeted distribution of pharmacological substances. Nanoscale vehicles, including liposomes, polymeric nanoparticles, and metal&#8211;organic frameworks (MOFs), are engineered to enhance pharmacokinetics and pharmacodynamics by controlled drug release, increased solubility, and less systemic toxicity. A key characteristic of nanocarriers is their capacity to precisely regulate medication release via customizable structural properties. Zhang et al. [<xref rid="B20-polymers-17-02497" ref-type="bibr">20</xref>] reported that the release kinetics of Celastrol from polyethylene glycol (PEG) derivatives were markedly affected by the steric hindrance of the outer shell, highlighting the direct impact of nanocarrier architecture on drug release. Soomherun et al. [<xref rid="B21-polymers-17-02497" ref-type="bibr">21</xref>] demonstrated that the porous characteristics of carboxymethyl cellulose and PLGA-based nanocarriers enabled the controlled release of Nicardipine hydrochloride in accordance with a first-order kinetic model, whereby the elevated polymer concentration enhanced porosity and affected drug diffusion rates. Biocompatibility and targeted delivery are critical components in the advancement of contemporary nanocarriers. Strategies like PEGylation&#8212;binding PEG chains to nanoparticle surfaces&#8212;prolong systemic circulation duration and diminish immunogenicity [<xref rid="B22-polymers-17-02497" ref-type="bibr">22</xref>]. Moreover, erythrocyte membrane-camouflaged nanocarriers have demonstrated enhanced tumor infiltration and cellular absorption, which is essential for cancer treatment [<xref rid="B23-polymers-17-02497" ref-type="bibr">23</xref>].</p><p>Zeolitic Imidazolate Framework-8 (ZIF-8), a subtype of metal&#8211;organic frameworks (MOFs), has garnered considerable interest among the developing nanocarrier platforms. ZIF-8 exhibits significant porosity, superior biocompatibility, and inherent pH sensitivity, rendering it especially appropriates for regulated drug release in pathological conditions like tumors or inflammatory areas [<xref rid="B24-polymers-17-02497" ref-type="bibr">24</xref>]. The pH-responsive behavior arises from the protonation of ZIF-8&#8217;s imidazolate ligands under acidic circumstances, leading to framework disintegration and subsequent drug release. The incorporation of amine groups has been documented to enhance the stability and compatibility of ZIF-8, hence facilitating improved drug loading and retention [<xref rid="B25-polymers-17-02497" ref-type="bibr">25</xref>].</p><p>Lipid-based nanocarriers demonstrate potential, especially in traversing biological barriers such as the blood&#8211;brain barrier. Feng et al. [<xref rid="B26-polymers-17-02497" ref-type="bibr">26</xref>] and Zhao et al. [<xref rid="B27-polymers-17-02497" ref-type="bibr">27</xref>] demonstrate that these systems enhance drug solubility and targeting efficacy, whereas ligand surface changes promote receptor-mediated uptake by Priya et al. [<xref rid="B28-polymers-17-02497" ref-type="bibr">28</xref>]. Besides independent nanocarriers, composite systems have also garnered attention. The use of kaolin, a naturally occurring biocompatible clay, with ZIF-8 presents synergistic benefits. The layered silicate structure of kaolin improves mechanical stability and offers an additional matrix for prolonged drug release [<xref rid="B27-polymers-17-02497" ref-type="bibr">27</xref>]. The composite formed with ZIF-8 leverages ZIF-8&#8217;s substantial drug-loading capacity and pH-responsive release characteristics, while kaolin contributes to reducing premature drug leakage and extending systemic retention.</p><p>The ZIF-8/kaolin hybrid has been emphasized as a versatile platform for biomedical applications. It has been suggested that these composites can efficiently navigate physiological obstacles within the gastrointestinal tract and demonstrate tissue-specific targeting, hence improving therapeutic efficacy and minimizing side effects [<xref rid="B29-polymers-17-02497" ref-type="bibr">29</xref>]. The hybrid system enhances the mechanical durability of the carrier and modifies surface properties critical for efficient drug interaction and biodistribution. Furthermore, the integration of stimuli-responsive mechanisms (such as pH- and temperature-sensitive release systems) enhances medication delivery. These intelligent carriers can initiate payload release under tumor-specific conditions (acidic pH or hyperthermia), offering spatial and temporal regulation of therapeutic activity [<xref rid="B30-polymers-17-02497" ref-type="bibr">30</xref>,<xref rid="B31-polymers-17-02497" ref-type="bibr">31</xref>]. The integration of kaolin and ZIF-8 into a cohesive nanocarrier platform corresponds with contemporary advances in precision medicine. This hybrid methodology utilizes the structural adaptability and responsiveness of metal&#8211;organic frameworks (MOFs) alongside the stability and biocompatibility of natural clays, signifying a promising strategy for advanced drug delivery systems.</p></sec><sec sec-type="conclusions" id="sec5-polymers-17-02497"><title>5. Conclusions</title><p>This study successfully synthesized and characterized ZIF and Kao@ZIF nanocarriers, and integrated them into a PLA&#8211;gelatin hydrogel matrix, forming a novel pH-responsive drug delivery platform. It had a high loading capacity and strong structural integrity, highlighting its suitability for localized NSAID administration. The developed systems exhibited excellent drug loading efficiencies (&gt;90%), pH-responsive release profiles, and structural robustness, especially in composite forms. The Kao@ZIF hybrid system showed additional advantages by combining ZIF&#8217;s efficient release characteristics with kaolin&#8217;s mechanical reinforcement and regulatory familiarity. These findings support the potential of ZIF-based composite carriers as viable platforms for localized and sustained delivery of poorly soluble drugs such as Naproxen.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Istanbul Technical University and Ac&#305;badem Mehmet Ali Ayd&#305;nlar University for their administrative and technical support throughout the study. The authors also acknowledge the use of shared laboratory infrastructure.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-polymers-17-02497"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/polym17182497/s1">https://www.mdpi.com/article/10.3390/polym17182497/s1</uri>, Figure S1: FT-IR spectra of synthesized ZIF (a) and pure Naproxen (b), highlighting characteristic peaks associated with each material; Figure S2: Particle size distribution of the synthesized ZIF, confirming nanoscale particle formation suitable for biomedical applications. Figure S3. SEM image of synthesized HNT-ZIF composite showing uniform ZIF deposition on the HNT surface and approximate particle dimensions; Figure S4. EDS spectrum of Naproxen-loaded ZIF embedded in PLA&#8211;gelatin hydrogel, showing preserved Zn signal and confirming the structural integrity of ZIF after drug incorporation; Figure S5. in vitro Cytotoxicity experiment results for Hydrogel-ZIF (A), ZIF-Naproxen (B) and Hydrogel-ZIF-Naproxen (C), indicating the improved cell viability for drug molecules after their encapsulation into hydrogel scaffold; Table S1. Average dry weights of PLA-only scaffolds, PLA&#8211;gelatin coated scaffolds, and PLA&#8211;gelatin hydrogels, demonstrating increased mass following gelatin and hydrogel integration.</p><supplementary-material id="polymers-17-02497-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="polymers-17-02497-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, O.G. and B.B.; methodology, O.G. and B.B.; validation, R.&#199;., O.G., and B.B.; formal analysis, R.&#199;.; investigation, B.A. and R.&#199;.; resources, R.&#199;. and B.A.; data curation, B.A. and R.&#199;.; writing&#8212;original draft preparation, R.&#199;.; writing&#8212;review and editing, R.&#199;., O.G., and B.B.; visualization, R.&#199;.; supervision, B.A., O.G., and B.B.; project administration, O.G. and B.B.; funding acquisition, O.G. and B.B. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All relevant data are included in the article and its <xref rid="app1-polymers-17-02497" ref-type="app">Supplementary Materials</xref>. Additional data are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ZIF</td><td align="left" valign="middle" rowspan="1" colspan="1">Zeolitic imidazolate frameworks</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Kao@</td><td align="left" valign="middle" rowspan="1" colspan="1">Kaolin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Kao@ZIF</td><td align="left" valign="middle" rowspan="1" colspan="1">Kaolin-ZIF </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PLA</td><td align="left" valign="middle" rowspan="1" colspan="1">Polylactic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MOF</td><td align="left" valign="middle" rowspan="1" colspan="1">Metal&#8211;organic frameworks</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NSAID</td><td align="left" valign="middle" rowspan="1" colspan="1">Nonsteroidal anti-inflammatory drug</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ATR</td><td align="left" valign="middle" rowspan="1" colspan="1">Attenuated total reflectance</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FT-IR</td><td align="left" valign="middle" rowspan="1" colspan="1">Fourier-transform infrared </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SEM</td><td align="left" valign="middle" rowspan="1" colspan="1">Scanning electron microscopy</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LC-M/MS</td><td align="left" valign="middle" rowspan="1" colspan="1">Liquid Chromatography-Tandem Mass Spectrometry</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMEM</td><td align="left" valign="middle" rowspan="1" colspan="1">Dulbecco&#8217;s Modified Eagle Medium</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FBS</td><td align="left" valign="middle" rowspan="1" colspan="1">Fetal bovine serum</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PSA</td><td align="left" valign="middle" rowspan="1" colspan="1">Penicillin&#8211;streptomycin&#8211;amphotericin </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EDS</td><td align="left" valign="middle" rowspan="1" colspan="1">Energy-dispersive X-ray spectroscopy</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EDL</td><td align="left" valign="middle" rowspan="1" colspan="1">Drug loading efficiency</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-polymers-17-02497"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Chakraborty</surname><given-names>K.</given-names></name><name name-style="western"><surname>An</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.K.</given-names></name></person-group><article-title>Pharmaceutical aspects of nanocarriers for smart anticancer therapy</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>1875</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13111875</pub-id><pub-id pub-id-type="pmid">34834290</pub-id><pub-id pub-id-type="pmcid">PMC8619450</pub-id></element-citation></ref><ref id="B2-polymers-17-02497"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bariwal</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mahato</surname><given-names>R.I.</given-names></name></person-group><article-title>Organic nanocarriers for delivery and targeting of therapeutic agents for cancer treatment</article-title><source>Adv. Ther.</source><year>2020</year><volume>3</volume><fpage>1900136</fpage><pub-id pub-id-type="doi">10.1002/adtp.201900136</pub-id></element-citation></ref><ref id="B3-polymers-17-02497"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanco</surname><given-names>E.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ferrari</surname><given-names>M.</given-names></name></person-group><article-title>Principles of nanoparticle design for overcoming biological barriers to drug delivery</article-title><source>Nat. Biotechnol.</source><year>2015</year><volume>33</volume><fpage>941</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1038/nbt.3330</pub-id><pub-id pub-id-type="pmid">26348965</pub-id><pub-id pub-id-type="pmcid">PMC4978509</pub-id></element-citation></ref><ref id="B4-polymers-17-02497"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baeza</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ruiz-Molina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vallet-Reg&#237;</surname><given-names>M.</given-names></name></person-group><article-title>Recent advances in porous nanoparticles for drug delivery in antitumoral applications: Inorganic nanoparticles and nanoscale metal-organic frameworks</article-title><source>Expert Opin. Drug Deliv.</source><year>2017</year><volume>14</volume><fpage>783</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1080/17425247.2016.1229298</pub-id><pub-id pub-id-type="pmid">27575454</pub-id></element-citation></ref><ref id="B5-polymers-17-02497"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>K.Z.</given-names></name><name name-style="western"><surname>Lan</surname><given-names>Y.Q.</given-names></name><name name-style="western"><surname>Su</surname><given-names>Z.M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>E.B.</given-names></name></person-group><article-title>Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle</article-title><source>Dalton Trans.</source><year>2012</year><volume>41</volume><fpage>6906</fpage><lpage>6909</lpage><pub-id pub-id-type="doi">10.1039/c2dt30357d</pub-id><pub-id pub-id-type="pmid">22580798</pub-id></element-citation></ref><ref id="B6-polymers-17-02497"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Crystalline structure and thermal stability of an unknown ZIF-L300 phase</article-title><source>Inorg. Chem.</source><year>2023</year><volume>62</volume><fpage>4385</fpage><lpage>4391</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c00160</pub-id><pub-id pub-id-type="pmid">36857465</pub-id></element-citation></ref><ref id="B7-polymers-17-02497"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattacharyya</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ham</surname><given-names>H.W.</given-names></name><name name-style="western"><surname>Sonh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gunbayar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jeffy</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nagarajan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Khatun</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Noh</surname><given-names>I.</given-names></name></person-group><article-title>3D bioprinting of complex tissue scaffolds with in situ homogeneously mixed alginate-chitosan-kaolin bioink using advanced portable biopen.</article-title><source>Carbohydr. Polym.</source><year>2023</year><volume>317</volume><fpage>121046</fpage><pub-id pub-id-type="pmid">37364947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.carbpol.2023.121046</pub-id></element-citation></ref><ref id="B8-polymers-17-02497"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bergaya</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lagaly</surname><given-names>G.</given-names></name></person-group><source>Handbook of Clay Science</source><edition>2nd ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2013</year><volume>Volume 5</volume></element-citation></ref><ref id="B9-polymers-17-02497"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name></person-group><article-title>Emerging nanoclay composite for effective hemostasis</article-title><source>Adv. Funct. Mater.</source><year>2018</year><volume>28</volume><fpage>1704452</fpage><pub-id pub-id-type="doi">10.1002/adfm.201704452</pub-id></element-citation></ref><ref id="B10-polymers-17-02497"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>M.</given-names></name><name name-style="western"><surname>G&#252;nter</surname><given-names>C.</given-names></name><name name-style="western"><surname>Taubert</surname><given-names>A.</given-names></name></person-group><article-title>Co-deposition of a hydrogel/calcium phosphate hybrid layer on 3D printed poly (lactic acid) scaffolds via dip coating: Towards automated biomaterials fabrication</article-title><source>Polymers</source><year>2018</year><volume>10</volume><elocation-id>275</elocation-id><pub-id pub-id-type="doi">10.3390/polym10030275</pub-id><pub-id pub-id-type="pmid">30966310</pub-id><pub-id pub-id-type="pmcid">PMC6414857</pub-id></element-citation></ref><ref id="B11-polymers-17-02497"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Motakef-Kazemi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Shojaosadati</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Morsali</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of the effect of nanoporous nanorods Zn2 (bdc) 2 (dabco) dimension on ibuprofen loading and release</article-title><source>J. Iran. Chem. Soc.</source><year>2016</year><volume>13</volume><fpage>1205</fpage><lpage>1212</lpage><pub-id pub-id-type="doi">10.1007/s13738-016-0835-9</pub-id></element-citation></ref><ref id="B12-polymers-17-02497"><label>12.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name></person-group><article-title>Development Type Selection of 3D Printing Base: Model Analysis and Empirical Study</article-title><source>Proceedings of the 5th International Conference on Advanced Design and Manufacturing Engineering</source><conf-loc>Shenzhen, China</conf-loc><conf-date>19&#8211;20 September 2015</conf-date><publisher-name>Atlantis Press</publisher-name><publisher-loc>Dordrecht, The Netherlands</publisher-loc><fpage>163</fpage><lpage>167</lpage></element-citation></ref><ref id="B13-polymers-17-02497"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>In situ encapsulation of cellulase in a novel mesoporous metal&#8211;organic framework</article-title><source>Catal. Lett.</source><year>2022</year><volume>152</volume><fpage>699</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1007/s10562-021-03672-y</pub-id></element-citation></ref><ref id="B14-polymers-17-02497"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>Halloysite nanotubes (HNTs)@ ZIF-67 composites&#8212;A new type of heterogeneous catalyst for the Knoevenagel condensation reaction</article-title><source>Dalton Trans.</source><year>2020</year><volume>49</volume><fpage>17621</fpage><lpage>17628</lpage><pub-id pub-id-type="doi">10.1039/D0DT03345F</pub-id><pub-id pub-id-type="pmid">33283809</pub-id></element-citation></ref><ref id="B15-polymers-17-02497"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>X.X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>N.</given-names></name></person-group><article-title>Chitosan coated biocompatible zeolitic imidazolate framework ZIF-90 for targeted delivery of anticancer drug methotrexate</article-title><source>J. Solid. State Chem.</source><year>2021</year><volume>300</volume><fpage>122259</fpage><pub-id pub-id-type="doi">10.1016/j.jssc.2021.122259</pub-id></element-citation></ref><ref id="B16-polymers-17-02497"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Junka</surname><given-names>R.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Anwar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name></person-group><article-title>Fabrication of polylactic acid (PLA)-based porous scaffold through the combination of traditional bio-fabrication and 3D printing technology for bone regeneration</article-title><source>Colloids Surf. B Biointerfaces</source><year>2021</year><volume>197</volume><elocation-id>111420</elocation-id><pub-id pub-id-type="doi">10.1016/j.colsurfb.2020.111420</pub-id><pub-id pub-id-type="pmid">33113493</pub-id><pub-id pub-id-type="pmcid">PMC7738389</pub-id></element-citation></ref><ref id="B17-polymers-17-02497"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maghsoudi</surname><given-names>M.A.F.</given-names></name><name name-style="western"><surname>Asbagh</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Tafti</surname><given-names>S.M.A.</given-names></name><name name-style="western"><surname>Aghdam</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Najjari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pirayvatlou</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Foroutani</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fazeli</surname><given-names>A.R.</given-names></name></person-group><article-title>Alginate-gelatin composite hydrogels loading zeolitic imidazolate framework-8 (ZIF-8) nanoparticles on gauze for burn wound healing: In vitro and in vivo studies</article-title><source>Int. J. Biol. Macromol.</source><year>2025</year><volume>295</volume><elocation-id>139348</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.139348</pub-id><pub-id pub-id-type="pmid">39743056</pub-id></element-citation></ref><ref id="B18-polymers-17-02497"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karaca</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Kan&#231;a&#287;&#305;</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>&#214;zbek</surname><given-names>U.</given-names></name><name name-style="western"><surname>Oval&#305;</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gok</surname><given-names>O.</given-names></name></person-group><article-title>Macro-Capsule Fabrication via 3D Printing for Mesenchymal Stem Cell Encapsulation</article-title><source>Int. J. Adv. Eng. Pure Sci.</source><year>2023</year><volume>35</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.7240/jeps.1115083</pub-id></element-citation></ref><ref id="B19-polymers-17-02497"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaharwar</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Cross</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Peak</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Gold</surname><given-names>K.</given-names></name><name name-style="western"><surname>Carrow</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Brokesh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>K.A.</given-names></name></person-group><article-title>2D nanoclay for biomedical applications: Regenerative medicine, therapeutic delivery, and additive manufacturing</article-title><source>Adv. Mater.</source><year>2019</year><volume>31</volume><fpage>1900332</fpage><pub-id pub-id-type="doi">10.1002/adma.201900332</pub-id><pub-id pub-id-type="pmcid">PMC6546555</pub-id><pub-id pub-id-type="pmid">30941811</pub-id></element-citation></ref><ref id="B20-polymers-17-02497"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>F.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name></person-group><article-title>a celastrol drug delivery system based on PEG derivatives: The structural effects of nanocarriers</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>1040</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28031040</pub-id><pub-id pub-id-type="pmid">36770710</pub-id><pub-id pub-id-type="pmcid">PMC9921568</pub-id></element-citation></ref><ref id="B21-polymers-17-02497"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soomherun</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kreua-ongarjnukool</surname><given-names>N.</given-names></name><name name-style="western"><surname>Niyomthai</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Chumnanvej</surname><given-names>S.</given-names></name></person-group><article-title>Kinetics of drug release via nicardipine hydrochloride-loaded carboxymethyl cellu-lose/poly (D, L-lactic-co-glycolic acid) nanocarriers using a contemporary emulsion process</article-title><source>ChemNanoMat</source><year>2020</year><volume>6</volume><fpage>1754</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.1002/cnma.202000528</pub-id></element-citation></ref><ref id="B22-polymers-17-02497"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>2717</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-59624-w</pub-id><pub-id pub-id-type="pmid">32066812</pub-id><pub-id pub-id-type="pmcid">PMC7026168</pub-id></element-citation></ref><ref id="B23-polymers-17-02497"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nie</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Cell membrane-camouflaged nanocarriers with biomimetic deforma-bility of erythrocytes for ultralong circulation and enhanced cancer therapy</article-title><source>ACS Nano</source><year>2022</year><volume>16</volume><fpage>6527</fpage><lpage>6540</lpage><pub-id pub-id-type="doi">10.1021/acsnano.2c00893</pub-id><pub-id pub-id-type="pmid">35426300</pub-id></element-citation></ref><ref id="B24-polymers-17-02497"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jermy</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Al-Jindan</surname><given-names>R.Y.</given-names></name><name name-style="western"><surname>Ravinayagam</surname><given-names>V.</given-names></name><name name-style="western"><surname>El-Badry</surname><given-names>A.A.</given-names></name></person-group><article-title>Anti-blastocystosis activity of antioxidant coated ZIF-8 combined with mesoporous silicas MCM-41 and KIT-6</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><elocation-id>6403</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-10397-4</pub-id><pub-id pub-id-type="pmid">35431315</pub-id><pub-id pub-id-type="pmcid">PMC9013716</pub-id></element-citation></ref><ref id="B25-polymers-17-02497"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kani</surname><given-names>S.N.M.</given-names></name><name name-style="western"><surname>Samadi-Maybodi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Najafzadehvarzi</surname><given-names>H.</given-names></name></person-group><article-title>Functionalized ZIF-8 with Aminopropyltrimethoxysilane as Montelukast Sodium Carrier for Medical Application</article-title><source>ChemistrySelect</source><year>2023</year><volume>8</volume><fpage>e202302774</fpage><pub-id pub-id-type="doi">10.1002/slct.202302774</pub-id></element-citation></ref><ref id="B26-polymers-17-02497"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name></person-group><article-title>Nanocarrier drug delivery system: Promising platform for targeted depression therapy</article-title><source>Front. Pharmacol.</source><year>2024</year><volume>15</volume><elocation-id>1435133</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2024.1435133</pub-id><pub-id pub-id-type="pmid">39119603</pub-id><pub-id pub-id-type="pmcid">PMC11306052</pub-id></element-citation></ref><ref id="B27-polymers-17-02497"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y.Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.X.</given-names></name></person-group><article-title>Lipid-based nanocarrier systems for drug delivery: Advances and applications</article-title><source>Pharm. Front.</source><year>2022</year><volume>4</volume><fpage>e43</fpage><lpage>e60</lpage><pub-id pub-id-type="doi">10.1055/s-0042-1751036</pub-id></element-citation></ref><ref id="B28-polymers-17-02497"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Priya</surname><given-names>S.</given-names></name><name name-style="western"><surname>Desai</surname><given-names>V.</given-names></name><name name-style="western"><surname>Singhvi</surname><given-names>G.</given-names></name></person-group><article-title>Surface modification of lipid-based nanocarriers: A potential approach to enhance targeted drug delivery</article-title><source>ACS Omega</source><year>2022</year><volume>8</volume><fpage>74</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1021/acsomega.2c05976</pub-id><pub-id pub-id-type="pmid">36643539</pub-id><pub-id pub-id-type="pmcid">PMC9835629</pub-id></element-citation></ref><ref id="B29-polymers-17-02497"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hossain</surname><given-names>S.</given-names></name><name name-style="western"><surname>Neogi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>T.</given-names></name></person-group><article-title>A Mini Overview of Biomedical Utilization of Zeolitic Imidazolate Frameworks</article-title><source>Proc. Int. Exch. Innov. Conf. Eng. Sci.</source><year>2023</year><volume>9</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.5109/7157963</pub-id></element-citation></ref><ref id="B30-polymers-17-02497"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soltani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Souri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moradi Kashkooli</surname><given-names>F.</given-names></name></person-group><article-title>Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><elocation-id>19350</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-98638-w</pub-id><pub-id pub-id-type="pmid">34588504</pub-id><pub-id pub-id-type="pmcid">PMC8481507</pub-id></element-citation></ref><ref id="B31-polymers-17-02497"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huynh</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>P.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Low-dose X-ray-responsive diselenide nanocarriers for effective delivery of anticancer agents</article-title><source>ACS Appl. Mater. Interfaces</source><year>2020</year><volume>12</volume><fpage>43398</fpage><lpage>43407</lpage><pub-id pub-id-type="doi">10.1021/acsami.0c11627</pub-id><pub-id pub-id-type="pmid">33003260</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="polymers-17-02497-f001" orientation="portrait"><label>Figure 1</label><caption><p>PLA scaffold: (<bold>a</bold>) disc model with inner pores; (<bold>b</bold>) 3D design with 2 mm height; (<bold>c</bold>) gelatin (10%)-embedded scaffold; (<bold>d</bold>) freeze-dried final scaffold.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g001.jpg"/></fig><fig position="float" id="polymers-17-02497-f002" orientation="portrait"><label>Figure 2</label><caption><p>Schematic representation of the synthesis and Naproxen loading process for ZIF and Kao@ZIF nanocarriers embedded in the PLA scaffold.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g002.jpg"/></fig><fig position="float" id="polymers-17-02497-f003" orientation="portrait"><label>Figure 3</label><caption><p>Comparative FT-IR spectra of pure ZIF, pure Naproxen, and ZIF-Naproxen composite confirming composite formation.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g003.jpg"/></fig><fig position="float" id="polymers-17-02497-f004" orientation="portrait"><label>Figure 4</label><caption><p>FT-IR spectra: (<bold>a</bold>) Kao@ZIF and (<bold>b</bold>) Kao@ZIF-Naproxen confirming Naproxen loading.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g004.jpg"/></fig><fig position="float" id="polymers-17-02497-f005" orientation="portrait"><label>Figure 5</label><caption><p>SEM images of (<bold>a</bold>) ZIF nanocarriers, (<bold>b</bold>) Kao@ZIF hybrids, and (<bold>c</bold>) PLA&#8211;gelatin interface.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g005.jpg"/></fig><fig position="float" id="polymers-17-02497-f006" orientation="portrait"><label>Figure 6</label><caption><p>SEM Images comparing the surface morphology of (<bold>a</bold>) Naproxen-loaded ZIF/PLA&#8211;gelatin composite and (<bold>b</bold>) Naproxen-loaded Kao@ZIF/PLA&#8211;gelatin hydrogel.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g006.jpg"/></fig><fig position="float" id="polymers-17-02497-f007" orientation="portrait"><label>Figure 7</label><caption><p>EDS spectra of (<bold>a</bold>) gelatin hydrogel, (<bold>b</bold>) Kao@ZIF nanocarriers, (<bold>c</bold>) ZIF-only nanocarriers, and (<bold>d</bold>) Kao@ZIF in gelatin hydrogel.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g007.jpg"/></fig><fig position="float" id="polymers-17-02497-f008" orientation="portrait"><label>Figure 8</label><caption><p>Cumulative drug release (%) of Naproxen from ZIF&#8211;Naproxen and Kao@ZIF&#8211;Naproxen systems embedded in PLA&#8211;gelatin hydrogel, tested in pH 7.4 and pH 5.5 buffers over 15 days.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g008.jpg"/></fig><fig position="float" id="polymers-17-02497-f009" orientation="portrait"><label>Figure 9</label><caption><p>Swelling capacity of PLA-gelatin hydrogel.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g009.jpg"/></fig><fig position="float" id="polymers-17-02497-f010" orientation="portrait"><label>Figure 10</label><caption><p>Cell viability results of free naproxen and its hydrogel loaded samples. Results are presented as mean &#177; SD (<italic toggle="yes">n</italic> = 3).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="polymers-17-02497-g010.jpg"/></fig><table-wrap position="float" id="polymers-17-02497-t001" orientation="portrait"><object-id pub-id-type="pii">polymers-17-02497-t001_Table 1</object-id><label>Table 1</label><caption><p>Drug loading efficiency after initial and secondary loading cycles.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Samples</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1st Loading Efficieny (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2nd Loading Efficieny (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">ZIF- Naproxen in PLA&#8212;Hydrogel</td><td align="center" valign="middle" rowspan="1" colspan="1">92.17</td><td align="center" valign="middle" rowspan="1" colspan="1">95.50</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Kao@ZIF- Naproxen in PLA&#8212;Hydrogel</td><td align="center" valign="middle" rowspan="1" colspan="1">92.95</td><td align="center" valign="middle" rowspan="1" colspan="1">83.71</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Naproxen&#8212;ZIF (free-form)</td><td align="center" valign="middle" rowspan="1" colspan="1">91.48</td><td align="center" valign="middle" rowspan="1" colspan="1">96.59</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naproxen&#8212;Kao@ZIF (free-form)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.14</td></tr></tbody></table></table-wrap><table-wrap position="float" id="polymers-17-02497-t002" orientation="portrait"><object-id pub-id-type="pii">polymers-17-02497-t002_Table 2</object-id><label>Table 2</label><caption><p>Ritger&#8211;Peppas kinetic parameters (<italic toggle="yes">n</italic> and k) for naproxen release from ZIF and Kao@ZIF nanocarriers at different pH values.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">System</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">pH</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic>-Value</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">k-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ZIF</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Kao@ZIF (HNT&#8211;ZIF)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ZIF</td><td align="center" valign="middle" rowspan="1" colspan="1">7.4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kao@ZIF (HNT&#8211;ZIF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">n</italic>: release exponent; k: kinetic constant.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>